RecruitingNCT07786818

Metatranscriptomic Markers of Colonic Neoplasia

Metatranscriptomic Markers As A Predictor of Colonic Neoplasia at the Time of Colonoscopy

Sponsor

Viome

Enrollment

1,000 participants

Start Date

Dec 20, 2025

Study Type

OBSERVATIONAL

Conditions

Colorectal Polyps

Summary

This study is a collaboration between Viome Life Sciences and Scripps Research Institute to develop and validate a noninvasive molecular diagnostic test for the detection of colorectal polyps. Approximately 1,000 participants undergoing colonoscopy will provide saliva and stool samples prior to their procedure. Molecular features identified in these samples will be evaluated in relation to colonoscopy findings to develop a predictive model for colorectal polyp detection. The resulting model will then be evaluated in an independent validation dataset to assess its performance for identifying individuals with colorectal polyps.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying This is an observational study that has no interventions for people with colorectal polyps. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.